2022

1. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

   The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 2, pp. 128-140

2. Multidimensional geriatric assessment

   Pathy's Principles and Practice of Geriatric Medicine (wiley), pp. 1231-1241